Regn Date : 29/01/2011 Name Regn No : MRS.

SHILPI PRASAD : 12112091

Age /Sex Rpt Date Ref Dr

: 38 Years

FEMALE

: 05/02/2011 : ANURADHA K

R E P O R T

SAMPLE TYPE

VDRL/STS TEST
RESULT NON REACTIVE

METHOD

: Rapid Plasma Reagin Test

(RPR)

INTERPRETATION :REACTIVE serum. : Indicates presence of anticardiolipin antibodies in the test

NON REACTIVE : Indicates absence of anticardiolipin antibodies in the test serum. NOTE : 1.This test is primarily a screening procedure. It is advisable to confirm positive samples with other methods employing specific treponemal antigen e.g. TPHA, FTA-ABS, etc. 2. Biological false positive results may be seen in presence of diseases such as Leprosy,Malaria ,Toxoplasmosis ,IM, SLE or high degree of bacterial contamination and incertain physiological conditions.
*** END OF REPORT ***

Verified By :

* Suggested Clinical correlation

If Necessary Kindly Discuss

Page 1 of 3

Regn Date : 29/01/2011 Name Regn No : MRS. SHILPI PRASAD : 12112091

Age /Sex Rpt Date Ref Dr

: 38 Years

FEMALE

: 05/02/2011 : ANURADHA K

R E P O R T

SAMPLE TYPE

DETECTION OF HUMAN HIV I & II ANTIBODIES

TEST
HIV TEST METHOD REFERENCE RANGES: NON REACTIVE BORDERLINE REACTIVE INTERPRETATION: 1.A negative result does not exclude the possibility of infection with HIV.Levels of HIV antibodies may be undetectable in the window period. 2.This test is a screening assay, it should not be used as a sole criterion for diagnosis of HIV infection.Its result should be confirmed by other supplementary methods.
*** END OF REPORT ***

RESULT
NON REACTIVE (0.06) ENHANCED CHEMILUMINESCENCE ASSAY

:0.00 - 0.89 :0.90 - 0.99 :More than /Equal to 1.00

Verified By :

* Suggested Clinical correlation

If Necessary Kindly Discuss

Page 2 of 3

Regn Date : 29/01/2011 Name Regn No : MRS. SHILPI PRASAD : 12112091

Age /Sex Rpt Date Ref Dr

: 38 Years

FEMALE

: 05/02/2011 : ANURADHA K

R E P O R T

SAMPLE TYPE

APTT (PARTIAL THROMBOPLASTIN TIME)

TEST RESULT NORMAL RANGE
26 - 36 seconds ACTIVATED PARTIAL THROMBOPLASTIN TIME 32.90
*** END OF REPORT ***

Verified By :

* Suggested Clinical correlation

If Necessary Kindly Discuss

Page 3 of 3